论文部分内容阅读
目的探讨促甲状腺激素(thyroid stimulating hormone,TSH)抑制疗法对老年甲状腺癌患者血清可溶性白细胞介素-2受体(soluble interleukin-2 receptor,s IL-2R)、白细胞分化抗原44变异型6(CD44V6)、肿瘤特异性生长因子(tumors pecific growth factor,TSGF)及外周血T淋巴细胞亚群(peripheral blood T lymphocyte subsets,PBTLS)影响。方法收集的本院收治的老年甲状腺癌患者5